Top Sell
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price ▼ | Potential |
|---|---|---|---|---|---|---|---|
| Larimar Therapeutics Inc. | 2 | 3 | 0 | 0 | €8.55 | €110.00 | 1186.550% |
| Mirati Therapeutics Inc. | 2 | 10 | 0 | 0 | €53.84 | €78.43 | 45.666% |
| Bristol-Myers Squibb | 8 | 2 | 0 | 0 | €46.38 | €70.25 | 51.472% |
| Cytomx Therapeutics Inc | 2 | 1 | 0 | 0 | €1.33 | €50.00 | 3670.739% |
| Agenus Inc. | 4 | 2 | 1 | 0 | €0.41 | €37.02 | 8846.834% |
| Sage Therapeutics Inc. | 8 | 4 | 1 | 0 | €9.57 | €25.88 | 170.460% |
| Palisade Bio Inc. | 3 | 1 | 0 | 0 | €0.34 | €21.06 | 6072.333% |
| Ironwood Pharmaceuticals | 8 | 1 | 0 | 0 | €6.30 | €18.80 | 198.367% |
| Moleculin Biotech Inc | 3 | 23 | 0 | 2 | €0.41 | €18.42 | 4393.659% |
| Elanco Animal Health Inc. | 8 | 3 | 1 | 0 | €11.81 | €15.66 | 32.640% |
| Cyclacel Pharmaceuticals Inc. | 2 | 10 | 0 | 0 | €0.22 | €14.66 | 6565.591% |
| Inotiv Inc. | 3 | 1 | 0 | 0 | €1.79 | €10.66 | 495.626% |
| Cellectar BioSciences Inc. | 8 | 7 | 3 | 1 | €2.10 | €10.55 | 402.181% |
| Glycomimetics Inc. | 5 | 3 | 0 | 1 | €0.22 | €7.35 | 3264.577% |
| Bluebird Bio Inc. | 4 | 6 | 0 | 0 | €1.10 | €6.49 | 489.591% |
| Trevena Inc. | 2 | 19 | 0 | 1 | €0.18 | €6.48 | 3541.573% |
| Chimerix Inc. | 3 | 1 | 0 | 0 | €0.82 | €5.51 | 573.333% |
| Gritstone Oncology Inc | 4 | 2 | 0 | 0 | €0.64 | €5.07 | 696.619% |
| Cara Therapeutics Inc. | 11 | 4 | 0 | 2 | €0.34 | €4.62 | 1268.780% |
| Fibrogen Inc. | 1 | 2 | 1 | 0 | €1.15 | €4.00 | 249.040% |
| Atara Biotherapeutics Inc. | 2 | 3 | 0 | 0 | €0.37 | €3.00 | 716.549% |
| Coherus Bioscien. | 1 | 2 | 0 | 0 | €1.47 | - | - |
| Aspira Womens Health Inc. | 0 | 1 | 0 | 0 | €1.31 | - | - |
| Evoke Pharma Inc. | 0 | 25 | 0 | 2 | €0.44 | - | - |
| Salarius Pharmaceuticals Inc. | 0 | 1 | 0 | 0 | €0.39 | - | - |